Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

Ventyx Biosciences (Nasdaq: VTYX), a clinical-stage biopharmaceutical firm, will participate in three upcoming investor conferences. The events are as follows: UBS Obesity Therapeutics Day on May 23, 2024, at 12:00-12:30 PM ET (virtual); Jefferies Global Healthcare Conference on June 6, 2024, at 11:00-11:25 AM ET in New York, NY; and Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, in Miami, FL. Webcasts for the UBS and Jefferies presentations will be accessible on the Ventyx website for 30 days post-event.

Positive

• Participation in high-profile investor conferences enhances visibility and credibility within the investment community.
• Engagements in diverse geographic locations (virtual, New York, and Miami) increase Ventyx's exposure to a broader audience.

Negative

• No specific financial or clinical data updates provided in the press release, potentially leaving investors without critical new information.
• Participation in conferences without concrete outcomes or announcements may not significantly impact the stock performance.

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:

• Event: UBS Obesity Therapeutics Day
  Location: Virtual
  Date: Thursday, May 23, 2024
  Time: 12:00-12:30 PM ET

• Event: Jefferies Global Healthcare Conference
  Location: New York, NY
  Date: Thursday, June 6, 2024
  Time: 11:00-11:25 AM ET

• Event: Goldman Sachs 45th Annual Global Healthcare Conference
  Location: Miami, FL
  Date: Tuesday, June 11, 2024

A webcast of the UBS and Jefferies presentations will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.

About Ventyx Biosciences

Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift inflammation and immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting NLRP3, S1P1R and TYK2, positioning us to become a leader in the development of oral immunology therapies for peripheral and neuroinflammatory diseases. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.

Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com

FAQ

When will Ventyx Biosciences participate in the UBS Obesity Therapeutics Day?

Ventyx Biosciences will participate in the UBS Obesity Therapeutics Day on May 23, 2024, from 12:00-12:30 PM ET.

Where is the Jefferies Global Healthcare Conference taking place?

The Jefferies Global Healthcare Conference will take place in New York, NY, on June 6, 2024.

How can I access the webcasts for Ventyx Biosciences' presentations?

Webcasts for the UBS and Jefferies presentations will be available on the Ventyx website in the Investors and News section, with replays available for 30 days post-event.

What is the stock symbol for Ventyx Biosciences?

The stock symbol for Ventyx Biosciences is VTYX.

What type of company is Ventyx Biosciences?

Ventyx Biosciences is a clinical-stage biopharmaceutical company focused on developing novel oral therapies for inflammatory diseases.